The Hidden Danger in a Baby’s Heartbeat: Why Early Screening for Congenital Heart Disease Matters

Every year, over 1 million babies worldwide are born with congenital heart disease (CHD). Many go undetected at birth — and early detection can be the difference between life and a lifetime of complications. Here’s why it matters, and how a new generation of AI-powered tools is about to change the game.

It Starts With a Murmur

Blue Baby from Mega Mind

Imagine this: a newborn passes the initial hospital checkup. The doctors listen with a stethoscope, note a faint sound, and mark the baby as healthy. The parents take their child home, full of joy.

Six months later, the baby struggles to breathe during feeding. At nine months, the parents notice the child isn’t gaining weight. At one year, a pediatrician finally orders an echocardiogram — and discovers a significant congenital heart defect that should have been caught at birth.

This isn’t a worst-case hypothetical. It’s a common reality in many parts of the world.

What Is Congenital Heart Disease?

A powerful reminder that progress in CHD care began with one bold breakthrough.

Congenital heart disease refers to structural problems with the heart that develop before birth. The spectrum ranges from small holes that close on their own to life-threatening malformations requiring immediate surgery.

The most common types include:

• Ventricular Septal Defect (VSD) — a hole in the wall between the heart’s lower chambers
• Atrial Septal Defect (ASD) — a hole between the upper chambers
• Patent Ductus Arteriosus (PDA) — when a blood vessel that should close after birth remains open
• Tetralogy of Fallot— a combination of four heart abnormalities

Some conditions are immediately life-threatening. Others are quieter, presenting as a heart murmur that a physician might easily miss or dismiss.

The Global Screening Gap

Newborn screening for CHD is far from universal. In high-income countries, pulse oximetry and clinical auscultation (listening with a stethoscope) are standard. Yet studies show that up to 30% of critical CHD cases are missed by current screening protocols.

In low- and middle-income countries, the gap is even wider. Shortages of pediatric cardiologists, limited access to echocardiograms, and overburdened primary care systems mean many children go years without a correct diagnosis.

The consequences are stark:

• Delayed treatment increases surgical risk and long-term complications
• Heart failure can develop before the child ever sees a specialist
• Developmental delays from chronic oxygen deprivation
• Preventable deaths — early detection enables timely intervention, significantly reducing CHD-related infant mortality (WHO — Congenital Anomalies)

Even in Indonesia, a country of over 270 million people, the ratio of pediatric cardiologists to children is staggeringly low. Access to specialized care is a privilege, not a given.

Why Heart Murmurs Are Hard to Catch

A heart murmur is an abnormal sound between heartbeats — a sign of turbulent blood flow, often caused by a structural defect. Experienced pediatric cardiologists can distinguish innocent murmurs from pathological ones with high accuracy. General practitioners, nurses, and midwives often cannot.

The problem is:

1. Human variability — skill and experience vary widely
2. Acoustic limitations — ambient noise, a restless baby, or a brief exam window can mask subtle sounds
3. Subjectivity — what one clinician hears as “probably fine,” another might miss entirely

This is precisely where artificial intelligence can make a profound difference.

AI-Powered Auscultation: A Stethoscope That Listens Smarter

The use of deep learning for automated heart sound classification has been an active area of research since the PhysioNet/Computing in Cardiology Challenge in 2016, which released a large public dataset of phonocardiogram (PCG) recordings. Since then, advances in convolutional and capsule neural networks have pushed classification accuracy significantly beyond general practitioner levels (Tsai YT et al., 2023; Bondareva E et al., 2021).

Imagine equipping every primary care clinic, midwife practice, and community health center with a digital stethoscope that doesn’t just amplify sound — it analyzes it in real time.

Stetoradr

This is the mission behind **Stetoradr — a project built by a my sone, himself a CHD survivor, tackling one of healthcare’s most persistent problems: early detection of heart murmurs in infants using AI**.

Using machine learning models trained on thousands of heart sound recordings, Stetoradr’s prototype stethoscope system can:

• Classify murmur patterns with accuracy exceeding general practitioners
• Flag suspicious sounds for immediate referral
• Operate in low-resource settings — no specialist required to interpret results
• Build a continuous learning loop — the more data it processes, the smarter it gets

This isn’t about replacing doctors. It’s about giving every baby the equivalent of a second opinion from a pediatric cardiologist automatically, affordably, at the point of care.

“Our goal is to make early CHD detection not a privilege of rich hospitals, but a standard part of every newborn checkup,” the Stetoradr team explains on their website.

⚕️ Important: AI Screening Is Not a Diagnosis

It’s critical to be clear about what Stetoradr is — and what it is not.

Stetoradr is an early screening tool, not a diagnostic device.

Heart murmurs can be caused by a wide range of conditions — from benign, innocent murmurs that require no treatment, to serious structural defects that require immediate intervention. No AI-powered stethoscope, however sophisticated, can definitively identify the exact nature of a heart defect from sound alone.

Echocardiography

The gold standard for diagnosing congenital heart disease remains the echocardiogram (ECHO) — an ultrasound-based imaging test that allows a pediatric cardiologist to directly visualize the heart’s structure and function. An echocardiogram can identify the precise location, size, and severity of any defect, guide surgical planning, and detect complications that no acoustic analysis can capture.

Stetoradr is designed to sit before the echocardiogram in the clinical workflow:

Think of it the way we think about a smoke detector: it alerts you that something might be wrong and you need to investigate further. It doesn’t tell you where the fire is or how big it is. The echocardiogram does that.

Why This Distinction Matters

1. Clinical safety — Over-reliance on AI without proper referral pathways could delay critical diagnoses. Any suspicious result from Stetoradr should prompt immediate referral for echocardiography.
2. Regulatory compliance — Medical device regulations (BPOM in Indonesia, FDA in the US, CE Mark in Europe) draw a clear line between screening and diagnostic devices. Misclassifying a screening tool as a diagnostic device creates serious legal and ethical liability.
3. Clinical trust — Healthcare providers need to understand exactly what a tool can and cannot do. Overclaiming undermines credibility; clear, honest positioning builds it.
4. Patient safety — Parents deserve accurate, complete information. A negative screen from an AI stethoscope does not rule out CHD. False negatives are possible, and the clinical context must always prevail.

Stetoradr’s honest positioning — as an affordable, accessible first-pass screening layer that exists to widen the net of detection, not replace the cardiologist — is actually its greatest strength. It doesn’t overreach. It does one essential job: catch more babies who might otherwise be missed.

And that is more than enough.

Disclaimer: Stetoradr is currently a prototype under development. It is not a certified medical device and should not be used as a substitute for professional medical evaluation. Any concerning findings should be followed up with a qualified pediatric cardiologist and echocardiogram.

Why This Matters Now More Than Ever

Global health systems are under pressure. Specialist shortages aren’t getting better. Meanwhile, the technology to build intelligent diagnostic tools has never been more accessible.

Early screening isn’t just about catching problems — it’s about:

• Reducing healthcare costs by enabling simpler, earlier interventions
• Improving survival rates through timely referrals
• Empowering frontline health workers with decision support
• Closing the equity gap between urban and rural healthcare access

The combination of portable hardware, edge AI, and cloud connectivity means a $50 device in a village clinic in Papua can now do what only a $50,000 echocardiogram machine could do a decade ago.

Stetoradr does not replace the echocardiogram. It exists to ensure more babies get to one.

The Road Ahead

We’re still in the early days. Stetoradr is prototyping. The technology needs validation, clinical trials, and regulatory approval. But the foundation is solid, the problem is urgent, and the direction is clear.

Every day we delay making AI-powered screening tools accessible, we lose babies we could have saved.

As parents, clinicians, engineers, and policymakers, we have a choice. We can continue relying on inconsistent human auscultation — or we can build systems that ensure no murmur goes unheard.

Stetoradr is building that system. And in the fight against congenital heart disease, that’s exactly the kind of disruption we need.

— -

About the Author

Rizki Suluh Adi is an AI entrepreneur, tech speaker, and father to a CHD kid. He writes about artificial intelligence, and digital transformation.

References & Further Reading

• World Health Organization — Congenital Anomalies Fact Sheet: who.int/news-room/fact-sheets/detail/birth-defects
• CDC — Birth Defects Overview: cdc.gov/birth-defects/about
• American Heart Association — About Congenital Heart Disease: heart.org/en/health-topics/congenital-heart-defects
• Stetoradr — AI-Powered Heart Murmur Screening: stetoradr.com
• Tsai YT et al. (2023) — Heart Murmur Classification Using a Capsule Neural Network, Bioengineering (Basel): pubmed.ncbi.nlm.nih.gov/38002361
• Bondareva E et al. (2021) — Segmentation-free Heart Pathology Detection Using Deep Learning, IEEE EMBC: pubmed.ncbi.nlm.nih.gov/34891381